Cape Cod Five Cents Savings Bank Gilead Sciences, Inc. Transaction History

Cape Cod Five Cents Savings Bank

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $327,554 - $357,368	4,430 New	4,430 $331,000
Q3 2020 Nov 10, 2020	SELL	$62.1 - $78.08 $170,464 - $214,329	-2,745 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $1,446 - $1,680	-20 Reduced 0.72%	2,745 $211,000
Q1 2020 May 11, 2020	BUY	$62.63 - $80.22 $173,171 - $221,808	2,765 New	2,765 $207,000
Q4 2018 Jan 16, 2019	SELL	$60.54 - $79.0 $183,496 - $239,449	-3,031 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$71.28 - $78.92 $13,471 - $14,915	-189 Reduced 5.87%	3,031 $234,000
Q2 2018 Jul 06, 2018	BUY	$64.88 - $75.68 $3,827 - $4,465	59 Added 1.87%	3,220 $228,000
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $6,846 - $8,347	-94 Reduced 2.89%	3,161 $238,000
Q4 2017 Feb 07, 2018	BUY	$71.15 - $83.52 $9,249 - $10,857	130 Added 4.16%	3,255 $233,000
Q3 2017 Nov 01, 2017	BUY	$72.11 - $85.47 $225,343 - $267,093	3,125	3,125 $253,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cape Cod Five Cents Savings Bank, based on Form 13F filings with the SEC.

Stay updated on Cape Cod Five Cents Savings Bank with notifications on news.